Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
AERIE PHARMACEUTICALS INCListing unverified | Sell | $5.2M | SEC | ||
Durata Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Durata Therapeutics, Inc.Listing unverified | Buy | $5.3M | conv 64ClusterFirst in 12mo | SEC | |
Durata Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AMARIN CORP PLC\UKListing unverified | Sell | $222.6K | SEC | ||
AMARIN CORP PLC\UKListing unverified | Sell | $4.4M | SEC | ||
Trius Therapeutics IncListing unverified | Other | $3.9M | SEC | ||
Trius Therapeutics IncListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Trius Therapeutics IncListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Trius Therapeutics IncListing unverified | Buy | $4.2M | conv 53ClusterFirst in 12mo | SEC | |
Trius Therapeutics IncListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |